United StatesCongress
hr 6513Bill

Medical Innovation Acceleration Act of 2022

To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.

Introduced on January 28, 2022

House
Senate
President